The future of the generics and biosimilars industry.
What future lies ahead for the generics and biosimilars industry? Is there only one possible future or even different futures that could await generic and biosimilar manufacturers?
Archive.
News from the industry
What future lies ahead for the generics and biosimilars industry? Is there only one possible future or even different futures that could await generic and biosimilar manufacturers?
Switzerland and the UK have recently been categorised as third countries by the EU. This affects trade relations between EU producers and producers from the UK and Switzerland.
The European Medicines Agency finds a solution that allows performing GMP and GDP inspections from remote.
The introduction of the COVID-19 vaccine is becoming the biggest challenge for chemical supply chains in history.
Under the title: "La Ola - was that the "perfect" wave?" our management consultant Dr. Ralf Hess gave an interview to the UNIversalis newspaper.
What the EU must do to make the pan-European health system crisis-proof in the future.
Dr Ralf Hess, Dominik M. Aumer, Moritz Haucke and Dr Simon Schulz publish articles on drug shortages and their causes in RAPS.
Research into a drug against SARS-CoV-2 is giving small molecules a renaissance.
How Corona exposes the failures in the European Health Service.
In addition to the development of new drugs against the coronavirus, tests are also being carried out at the same time to see whether developed drugs, some of which have already been approved, can be repurposed in the fight against the virus.
Due to the SARS-CoV-2 pandemic, the EU has proposed to postpone the start of the new MDR by 1 year.
The emergence of a vaccine and an outlook on when a vaccine to protect against SARS-CoV-2 infection might be available.
No matter what you understand by digitalisation: Corona will significantly change the implementation of digitalisation
Transmission of 2019-nCoV infection through asymptomatic contact in Germany.
The "Corona crisis" calls for tough measures. These include so-called non-pharmaceutical interventions, which also include "social distancing".
Dr Ralf Hess, PhD, biologist and member of the Entourage Task Force, on travel and safety advice regarding the coronavirus.
Entourage Principal Project Consultant Dr Ralf Hess publishes article on the implementation of MDR & IVDR into national law. In Regulatory Focus. September 2019. Regulatory Affairs Professionals Society.
